Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Wednesday 16 February 2022 8:40 am

AIDS scientists cure human for the first time: Former HIV patient is off medication, asymptomatic and healthy

By: Michiel Willems

Add as a preferred source on Google

Researchers in the U.S. have said they have cured HIV in a human being for the very first time.

The scientists said the mixed-race New York woman, who was previously HIV positive, was now “off medication, asymptomatic and healthy”, according to various media reports.

The scientists reportedly used a cutting-edge stem cell transplant method that they expect will expand the pool of people who could receive similar treatment to several dozen annually.

“The patient stepped into a rarified club that includes three men whom scientists have cured, or very likely cured, of HIV. Researchers also know of two women whose own immune systems have, quite extraordinarily, apparently vanquished the virus,” according to NBC News.

Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, one of multiple divisions of the National Institutes of Health that funds the research network behind the new case study, told NBC News that the accumulation of repeated apparent triumphs in curing HIV “continues to provide hope.” 

“It’s important that there continues to be success along this line,” he said.

“We are very excited” about the new case of possible HIV cure, said Dr. Deborah Persaud, a paediatric infectious disease specialist at the Johns Hopkins University School of Medicine who chairs the NIH-funded scientific committee behind the new case study, the International Maternal Pediatric Adolescent AIDS Clinical Trials Network.

However, Persaud did stress the stem cell treatment method is “still not a feasible strategy for all but a handful of the millions of people living with HIV.”

Read more

Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Pharmaceuticals
  • Pharmaceuticals

Trending Articles

  • Billionaire Easyjet founder in line for £800m payday from takeover

  • The former African gold miner taking on the billionaire Issa brothers

  • Tesco ‘in talks’ to exit eastern Europe

  • Pension pressure to help swell UK debt to three times size of economy

  • As it happened: FTSE 100 slump as oil soars; Trump says Iran will be ‘hit hard’ tonight

More from City PM

  • Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

    Business Wire
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

    Business Wire
  • Exclusive: Top FTSE executive recruiter goes bust after AI platform launch

    Business
    Consultancy sector and AI
  • GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

    Tech
    GSK said total sales fell by two per cent in the third quarter
  • The ‘like’ button ruined social media – are we making the same mistake with AI?

    Opinion
    Twitter logo displayed on a digital screen, symbolizing its influential role in social media and online communication trends.
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • Book review: The Reverse Centaur’s Guide to Life After AI by Cory Doctorow

    Life&Style
    GettyImages 2240900371 portrays a significant business event with professionals networking in a modern conference setting.

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook